NAUT (Nautilus Biotechnology, Inc.) Stock Financials & Earnings

NAUTNautilus Biotechnology, Inc.

Mkt Cap$339M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$59M

EPS (TTM)-$0.47

Free Cash Flow (TTM)-$52M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$1M	-$18M
Q2 23	$0	-$1M	-$19M
Q3 23	$0	-$2M	-$19M
Q4 23	$0	-$2M	-$20M
Q1 24	$0	-$2M	-$22M
Q2 24	$0	-$2M	-$21M
Q3 24	$0	-$2M	-$19M
Q4 24	$0	-$6M	-$20M
Q1 25	$0	-$2M	-$19M
Q2 25	$0	-$2M	-$17M
Q3 25	$0	-$2M	-$15M
Q4 25	$0	-$2M	-$15M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$10M	—	$6M
Q2 23	$12M	—	$6M
Q3 23	$11M	—	$6M
Q4 23	$12M	—	$7M
Q1 24	$12M	—	$8M
Q2 24	$12M	—	$7M
Q3 24	$12M	—	$6M
Q4 24	$11M	—	$3M
Q1 25	$11M	—	$6M
Q2 25	$10M	—	$6M
Q3 25	$9M	—	$5M
Q4 25	$11M	$26M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$89M	$79M	$167M
Q2 23	$72M	$91M	$163M
Q3 23	$74M	$109M	$183M
Q4 23	$19M	$154M	$173M
Q1 24	$26M	$156M	$181M
Q2 24	$25M	$143M	$167M
Q3 24	$4M	$136M	$141M
Q4 24	$28M	$102M	$130M
Q1 25	$33M	$106M	$139M
Q2 25	$34M	$113M	$148M
Q3 25	$24M	$108M	$131M
Q4 25	$12M	$91M	$103M

Shares Outstanding

Revenue Per Employee

Revenue / Employee